Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome

Published:2010-05-06 Issue:18 Volume:362 Page:1746-1748
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Zimmerhackl Lothar Bernd,Hofer Johannes,Cortina Gérard,Mark Walter,Würzner Reinhard,Jungraithmayr Therese C.,Khursigara Gus,Kliche Kay O.,Radauer Wolfgang

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc1001060

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation;Transplantation Reviews;2024-07

2. Atypical hemolytic uremic syndrome: Consensus of diagnosis and treatment in Taiwan;Journal of the Formosan Medical Association;2023-05

3. Haemolytic Uremic Syndrome: A Study Cohort over 10-Year Period in a Paediatric Tertiary Centre Hospital;Nephron;2022-12-21

4. First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient;Transplant International;2022-10-03

5. CRISPR/Cas-edited pigs for personalized medicine: more than preclinical test-system;Research Results in Pharmacology;2022-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP